Contribution of metabolic risk factors and lifestyle behaviors to cardiovascular disease: A mendelian randomization

Yiming Jia1, Rong Wang2, Daoxia Guo3

  • 1Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.

Insights

This study used Mendelian randomization to find 11 modifiable risk factors for cardiovascular disease (CVD). These findings highlight key targets for preventing coronary artery disease (CAD) and ischemic stroke.

Area of Science:

  • Cardiovascular Epidemiology
  • Genetic Epidemiology
  • Public Health

Background:

  • Causal links between modifiable factors and cardiovascular disease (CVD) require further clarification.
  • Identifying these links is crucial for developing effective CVD prevention strategies.

Purpose of the Study:

  • To investigate the causal associations of 15 modifiable risk factors with coronary artery disease (CAD) and ischemic stroke.
  • To identify potential targets for CVD prevention through a robust analytical approach.

Main Methods:

  • Employed a two-sample Mendelian randomization (MR) method.
  • Utilized large-scale genome-wide association study (GWAS) data for exposures (e.g., blood pressure, lipids, lifestyle behaviors) and outcomes (CAD and ischemic stroke).

Main Results:

  • Confirmed causal relationships between 11 modifiable factors and CVD.
  • Significant associations were found for hypertension, systolic and diastolic blood pressure, type 2 diabetes, smoking initiation, educational attainment, LDL cholesterol, HDL cholesterol, triglycerides, body mass index, and alcohol dependence.

Conclusions:

  • Identified 11 modifiable factors as significant causal risk factors for CVD.
  • These factors represent important targets for public health interventions aimed at CVD prevention.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
74
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
138
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
163
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
280